Annual Operating Expenses
$228.37 M
+$42.64 M+22.96%
December 31, 2024
Summary
- As of March 9, 2025, PLRX annual total operating expenses is $228.37 million, with the most recent change of +$42.64 million (+22.96%) on December 31, 2024.
- During the last 3 years, PLRX annual operating expenses has risen by +$123.26 million (+117.27%).
- PLRX annual operating expenses is now at all-time high.
Performance
PLRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$53.32 M
-$8.69 M-14.02%
December 31, 2024
Summary
- As of March 9, 2025, PLRX quarterly total operating expenses is $53.32 million, with the most recent change of -$8.69 million (-14.02%) on December 31, 2024.
- Over the past year, PLRX quarterly operating expenses has dropped by -$8.69 million (-14.02%).
- PLRX quarterly operating expenses is now -14.02% below its all-time high of $62.01 million, reached on September 30, 2024.
Performance
PLRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PLRX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.0% | -14.0% |
| 3 y3 years | +117.3% | -14.0% |
| 5 y5 years | +291.8% | -14.0% |
PLRX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +117.3% | -14.0% | +100.5% |
| 5 y | 5-year | at high | +291.8% | -14.0% | +259.5% |
| alltime | all time | at high | +638.7% | -14.0% | +299.0% |
Pliant Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $228.37 M(+23.0%) | $53.32 M(-14.0%) |
| Sep 2024 | - | $62.01 M(+2.3%) |
| Jun 2024 | - | $60.64 M(+15.7%) |
| Mar 2024 | - | $52.39 M(+11.4%) |
| Dec 2023 | $185.72 M(+35.7%) | $47.04 M(-1.4%) |
| Sep 2023 | - | $47.69 M(+0.2%) |
| Jun 2023 | - | $47.58 M(+9.6%) |
| Mar 2023 | - | $43.43 M(+10.3%) |
| Dec 2022 | $136.88 M(+30.2%) | $39.37 M(+17.8%) |
| Sep 2022 | - | $33.43 M(-3.5%) |
| Jun 2022 | - | $34.63 M(+17.6%) |
| Mar 2022 | - | $29.46 M(+10.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $105.11 M(+25.9%) | $26.60 M(-7.4%) |
| Sep 2021 | - | $28.72 M(+16.3%) |
| Jun 2021 | - | $24.69 M(-1.6%) |
| Mar 2021 | - | $25.09 M(+6.9%) |
| Dec 2020 | $83.46 M(+43.2%) | $23.48 M(+9.3%) |
| Sep 2020 | - | $21.48 M(+4.4%) |
| Jun 2020 | - | $20.58 M(+14.8%) |
| Mar 2020 | - | $17.93 M(+20.9%) |
| Dec 2019 | $58.28 M(+88.5%) | $14.83 M(+11.0%) |
| Sep 2019 | - | $13.36 M(-15.1%) |
| Jun 2019 | - | $15.74 M(+9.7%) |
| Mar 2019 | - | $14.35 M |
| Dec 2018 | $30.91 M | - |
FAQ
- What is Pliant Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Pliant Therapeutics?
- What is Pliant Therapeutics annual operating expenses year-on-year change?
- What is Pliant Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly operating expenses year-on-year change?
What is Pliant Therapeutics annual total operating expenses?
The current annual operating expenses of PLRX is $228.37 M
What is the all time high annual operating expenses for Pliant Therapeutics?
Pliant Therapeutics all-time high annual total operating expenses is $228.37 M
What is Pliant Therapeutics annual operating expenses year-on-year change?
Over the past year, PLRX annual total operating expenses has changed by +$42.64 M (+22.96%)
What is Pliant Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of PLRX is $53.32 M
What is the all time high quarterly operating expenses for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly total operating expenses is $62.01 M
What is Pliant Therapeutics quarterly operating expenses year-on-year change?
Over the past year, PLRX quarterly total operating expenses has changed by -$8.69 M (-14.02%)